Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Acquired Diseases
  • Published:

8 Br-cAMP enhances both humoral and cell-mediated immune responses induced by an HIV-1 DNA vaccine

Gene Therapy volume 7, pages 694–702 (2000)Cite this article

Abstract

From a series of preclinical studies and animal experiments, we have been able to demonstrate that DNA vaccines are a promising tool in strategies for protecting hosts from a variety of infectious diseases. Since the promoter activity of the human cytomegalovirus immediate–early promoter/ enhancer (CMV promoter) is known to be responsive to an elevation in the level of intracellular cAMP, we hypothesized that use of cAMP analogue (8-Bromo adenosine 3′5′-cyclic monophosphate, 8 Br-cAMP) would increase the level of transgene expression supported by the CMV, and enhance the ability of DNA vaccines to evoke an immune response against the transgene product in vivo. To evaluate this hypothesis, immune responses against HIV-1 envelope protein, gp160, an immunogenic HIV-1 component expressed under the control of the CMV promoter, were evaluated in BALB/c mice with or without stimulation by 8 Br-cAMP. DNA vaccine with 8 Br-cAMP was intramuscularly (i.m.) or intranasally (i.n.) administered to BALB/c mice twice on days 0 and 14. Regardless of which route was used, the combination increased the serum IgG antibody (Ab) titer, HIV-1-specific cytotoxic T lymphocyte (CTL) activity and the delayed-type hypersensitivity (DTH) response, compared with the effect of using the vaccine alone. When administered via the i.n. route, the combination also remarkably increased the titer of secretory IgA (sIgA). Moreover, it induced increased production of interferon-γ with reduction in IL-4 synthesis, and decreased the ratio of serum IgG1/IgG2a. However, these enhancements were not observed when 8 Br-cAMP was coadministered with peptide vaccine or protein antigen. These data suggest that 8 Br-cAMP is able to enhance both humoral and cellular immune responses induced by the DNA vaccine. The induction of T helper type 1 (Th1) immunity against HIV-1 was also enhanced by coadministration of 8 Br-cAMP. A CAT assay study demonstrated that the adjuvant effect of 8 Br-cAMP may be due to the activation of the CMV promoter in the DNA vaccine. The virus challenge experiment in a mouse influenza model also proved our hypothesis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Donnelly JJ et al. DNA vaccines Annu Rev Immunol 1997 15: 617–648

    Article  CAS  Google Scholar 

  2. Boyer J et al. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination Nature Med 1997 3: 526–532

    Article  CAS  Google Scholar 

  3. Manichan E et al. Genetic immunization against herpes simplex virus: protection is mediated by CD4+ T lymphocytes J Immunol 1995 155: 259–265

    Google Scholar 

  4. Lu S et al. Simian immunodeficiency virus DNA vaccine trial in macaques J Virol 1996 70: 3978–3991

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Ghiasi H et al. Vaccination of mice with herpes simplex virus type 1 glycoprotein D DNA produces low levels of protection against lethal HSV-1 challenge Antivir Res 1995 28: 147–157

    Article  CAS  Google Scholar 

  6. Okuda K et al. Induction of potent humoral and cell-mediated immune responses following direct injection of DNA encoding the HIV-1 env and rev gene products AIDS Res Hum Retrovir 1995 11: 933–943

    Article  CAS  Google Scholar 

  7. Xin K-Q et al. IL-15 expression plasmid enhances cell-mediated immunity induced by an HIV-1 DNA vaccine Vaccine 1999 17: 858–866

    Article  CAS  Google Scholar 

  8. Xin K-Q et al. Immunization of RANTES expression plasmid with a DNA vaccine enhances HIV-1-specific immunity Clin Immunol 1999 92: 90–96

    Article  CAS  Google Scholar 

  9. Xin K-Q et al. Intranasal administration of HIV-1 DNA vaccine with IL-2 expression plasmid enhances cell-mediated immunity against HIV-1 Immunol 1998 94: 438–444

    Article  CAS  Google Scholar 

  10. Tsuji T et al. Enhancement of cell-mediated immunity against HIV-1 induced by coinoculation of plasmid-encoded HIV-1 antigen with plasmid expressing interleukin-12 J Immunol 1997 158: 4008–4013

    CAS  Google Scholar 

  11. Lu Y et al. Macrophage inflammatory protein-1α (MIP-1α) expression plasmid enhances the immune response to DNA vaccination against human immunodeficiency virus type 1 Clin Exp Immunol 1999 115: 335–341

    Article  CAS  Google Scholar 

  12. Tsuji T et al. HIV-1-specific cell-mediated immunity is enhanced by co-inoculation of TCA3 expression plasmid DNA vaccine Immunol 1997 90: 1–6

    Article  CAS  Google Scholar 

  13. Tsuji T et al. Immunodulatory effects of plasmid expressing B7-2 on human immunodeficiency virus-1 specific cell-mediated immunity induced by plasmid-encoded the viral antigen Eur J Immunol 1997 27: 782–787

    Article  CAS  Google Scholar 

  14. Sasaki S et al. Adjuvant effect of Ubenimex on a DNA vaccine for HIV-1 Clin Exp Immunol 1998 111: 30–35

    Article  CAS  Google Scholar 

  15. Sasaki S et al. Monophosphoryl lipid A enhances both humoral and cell-mediated immune responses to DNA vaccination against human immunodeficiency virus type 1 Infect Immun 1997 65: 3520–3528

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Ishii N et al. Cationic liposomes are a strong adjuvant for a human immunodeficiency virus type-1 (HIV-1) vaccine candidate constructed with HIV-1 env and rev genes AIDS Res Hum Retrovir 1997 13: 1421–1428

    Article  CAS  Google Scholar 

  17. Fickenscher H et al. The role of a repetitive palindromic sequence element in the human cytomegalovirus major immediate–early enhancer J Gen Virol 1989 70: 107–123

    Article  CAS  Google Scholar 

  18. Boshart M et al. A very strong enhancer is located upstream of an immediate–early gene of human cytomegalovirus Cell 1985 41: 521–530

    Article  CAS  Google Scholar 

  19. Stamminger T, Fickenscher H, Fleckenstein B . Cell-type specific induction of the major immediate–early enhancer of human cytomegalovirus by cyclic AMP J Gen Virol 1990 71: 105–113

    Article  CAS  Google Scholar 

  20. Graham B, Wright P . Candidate AIDS vaccines New Engl J Med 1995 333: 1331–1339

    Article  CAS  Google Scholar 

  21. Bolognesi DP et al. HIV vaccine development: a progress report Ann Intern Med 1994 8: 603–611

    Google Scholar 

  22. Girard M et al. Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1 J Virol 1995 69: 6239–6248

    CAS  PubMed  PubMed Central  Google Scholar 

  23. EL-Amed Z et al. Resistance of chimpanzees immunized with recombinant gp120 SF-2 to challenge by HIV-1 SF-2 AIDS 1995 9: 1313–1322

    Article  Google Scholar 

  24. Berman P et al. Protection of MN rgp120-immunized chimpanzees from heterologous infection with a primary isolated of human immunodficiency virus type 1 J Infect Dis 1996 173: 52–59

    Article  CAS  Google Scholar 

  25. Connor R et al. Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines J Virol 1998 72: 1552–1576

    CAS  PubMed  PubMed Central  Google Scholar 

  26. Fynan EF et al. DNA vaccines: a novel approach to immunization Int J Immunopharmac 1995 17: 79–83

    Article  CAS  Google Scholar 

  27. Germain RN . The ins and outs of antigen processing and presentation Nature 1986 322: 687–689

    Article  CAS  Google Scholar 

  28. Miedema F, Klein MR . AIDS pathogenesis: a finite immune response to blame? Science 1996 272: 505–506

    Article  CAS  Google Scholar 

  29. Haynes BF, Pantaleo G, Fauci AS . Toward an understanding of the correlates of protective immunity to HIV infection Science 1996 271: 324–328

    Article  CAS  Google Scholar 

  30. Koup RA et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome J Virol 1994 68: 4650–4655

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Pantaleo G et al. Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIV Nature 1994 370: 463–467

    Article  CAS  Google Scholar 

  32. Klein MR et al. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics J Exp Med 1995 181: 1365–1372

    Article  CAS  Google Scholar 

  33. Langlade-Demoyen P et al. Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients J Clin Invest 1994 93: 1293–1297

    Article  CAS  Google Scholar 

  34. Rowland-Jones S et al. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women Nature Med 1995 1: 59–64

    Article  Google Scholar 

  35. McAnelly L, Zakon HH . Protein kinase A activation increases sodium current magnitude in the electric organ of Sternopygus J Neurosci 1996 16: 4383–4388

  36. Shintani Y, Marunaka Y . Regulation of chloride channel trafficking by cyclic AMP via protein kinase A-independent pathway in A6 renal epithelial cells Biochem Biophys Res Commun 1996 223: 234–239

    Article  CAS  Google Scholar 

  37. Gupta MP et al. Sympathetic control of cardiac myosin heavy chain gene expression Mol Cell Biochem 1996 157: 117–124

    Article  CAS  Google Scholar 

  38. Cerne R, Rusin KI, Randic M . Enhancement of the N-methyl-D-aspartate response in spinal dorsal horn neurons by cAMP-dependent protein kinase Neurosci Lett 1993 161: 124–128

    Article  CAS  Google Scholar 

  39. Bukawa H et al. Neutralization of HIV-1 by secretory IgA induced by oral immunization with a new macromolecular multicomponent peptide vaccine candidate Nature Med 1995 1: 681–685

    Article  CAS  Google Scholar 

  40. Clerici M et al. Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individual J Immunol 1991 146: 2214–2219

    CAS  PubMed  Google Scholar 

  41. Staats FH, Nichols WG, Palker TJ . Systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide TSP10MN (A) J Immunol 1996 157: 462–472

    CAS  PubMed  Google Scholar 

  42. Shirai A et al. Individual cells simultaneously produce both IL-4 and IL-6 in vivo Cytokine 1994 6: 329–336

    Article  CAS  Google Scholar 

  43. Ulmer JB et al. Heterologous protection against influenza by injection of DNA encoding a viral protein Science 1993 259: 1745–1749

    Article  CAS  Google Scholar 

  44. Montgomery DL et al. Heterologous and homologous protection against influenza A by DNA vaccination: optimization of vectors DNA Cell Biol 1993 12: 777–783

    Article  CAS  Google Scholar 

  45. Robinson HL, Hunt LA, Webster RG . Protection against a lethal influenza challenge by immunization with a hemagglutinin-expressing plasmid DNA Vaccine 1993 11: 957–960

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We are grateful to Ms T Sasaki, A Honsho and T Takeishi for their secretarial assistance. This work was partially supported by a Grant-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan and The Japan Health Sciences Foundation (K-1027).

Author information

Authors and Affiliations

  1. Department of Bacteriology, Yokohama City University School of Medicine, Yokohama, Japan

    H Arai, K-Q Xin, K Hamajima, Y Lu, S Watabe, T Takahashi, S Toda & K Okuda

  2. Department of Microbiology, Tokyo Dental College, Chiba, Japan

    K Okuda

  3. Department of Anesthesiology, Yokohama City University School of Medicine, Yokohama, Japan

    I Kudoh

  4. Department of Internal Medicine, Yokohama City University School of Medicine, Yokohama, Japan

    M Suzuki

Authors
  1. H Arai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K-Q Xin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K Hamajima
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S Watabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. T Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. S Toda
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. K Okuda
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. I Kudoh
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. M Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. K Okuda
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arai, H., Xin, KQ., Hamajima, K. et al. 8 Br-cAMP enhances both humoral and cell-mediated immune responses induced by an HIV-1 DNA vaccine. Gene Ther 7, 694–702 (2000). https://doi.org/10.1038/sj.gt.3301145

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301145

Keywords

Search

Advanced search

Quick links